Zymeworks Inc. Forecast, price target & analysts
Zymeworks Inc. Target price 2025 - Analyst rating & recommendation
Zymeworks Inc. Classifications & Recommendation:
Zymeworks Inc. Price Target
| Target Price | $21.56 |
| Price | $10.63 |
| Potential |
102.78%
register free of charge
|
| Number of Estimates | 9 |
|
9 Analysts have issued a price target Zymeworks Inc. 2026 .
The average Zymeworks Inc. target price is $21.56.
This is
102.78%
register free of charge
$30.00
182.22%
register free of charge
$12.00
12.89%
register free of charge
|
|
| A rating was issued by 9 analysts: 7 Analysts recommend Zymeworks Inc. to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Zymeworks Inc. stock has an average upside potential 2026 of
102.78%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 76.30 | 94.41 |
| 0.38% | 23.73% | |
| EBITDA Margin | -142.37% | -136.76% |
| 10.38% | 3.94% | |
| Net Margin | -147.63% | -123.23% |
| 6.17% | 16.53% |
7 Analysts have issued a sales forecast Zymeworks Inc. 2025 . The average Zymeworks Inc. sales estimate is
This results in the following potential growth metrics:
2 Analysts have issued an Zymeworks Inc. EBITDA forecast 2025. The average Zymeworks Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
8 Zymeworks Inc. Analysts have issued a net profit forecast 2025. The average Zymeworks Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.62 | -1.67 |
| 5.81% | 3.09% | |
| P/E | negative | |
| EV/Sales | 5.70 |
8 Analysts have issued a Zymeworks Inc. forecast for earnings per share. The average Zymeworks Inc. EPS is
This results in the following potential growth metrics and future valuations:
Current Zymeworks Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| LifeSci Capital |
Locked
➜
Locked
|
Locked | Mar 11 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 10 2025 |
| Citigroup |
Locked
➜
Locked
|
Locked | Mar 07 2025 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Dec 19 2024 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Dec 16 2024 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 22 2024 |
| Leerink Partners |
Locked
➜
Locked
|
Locked | Nov 07 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
LifeSci Capital:
Locked
➜
Locked
|
Mar 11 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 10 2025 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Mar 07 2025 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Dec 19 2024 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Dec 16 2024 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 22 2024 |
|
Locked
Leerink Partners:
Locked
➜
Locked
|
Nov 07 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
